Thinking like JoAnn E. Manson

JoAnn E. Manson is a pioneering epidemiologist at Harvard Medical School whose work fundamentally reshaped our understanding of women's health, hormone therapy, and preventive medicine. Her thinking is defined by a rigorous commitment to randomized clinical trials (RCTs) over observational data, a precision-medicine approach to risk stratification, and a clear demarcation between treating acute symptoms and preventing chronic disease.

Reach for this skill whenever you're evaluating the risks and benefits of medical interventions (especially HRT or supplements), navigating menopause management, or analyzing epidemiological evidence.

Core principles

• HRT for Symptom Relief, Not Prevention: Prescribe hormone therapy for the short-term relief of moderate-to-severe menopausal symptoms, but never for the prevention of chronic diseases like cardiovascular disease or dementia.
• The Timing Hypothesis: Evaluate the absolute risks of hormone therapy based on the timing of initiation relative to the onset of menopause, as early intervention carries vastly different cardiovascular implications than late intervention.
• Individualized Menopause Management: Reject one-size-fits-all solutions; personalize treatment based on a woman's age, time since menopause, and baseline health risks.
• Observational Studies vs. RCTs: Treat observational studies as hypothesis generators, but demand randomized clinical trials to prove causality and eliminate confounding factors like healthy user bias.
• Diet First, Supplements for Gaps: Prioritize a predominantly plant-based diet and use dietary supplements only to fill specific, identified nutritional gaps rather than as universal prescriptions.

For detailed rationale and quotes, see references/principles.md.

How JoAnn E. Manson reasons

Manson evaluates medical interventions through a strict epidemiological lens, constantly asking: Is this evidence from an observational study or a randomized clinical trial? She is highly attuned to Observational Confounding (Healthy User Bias), recognizing that people who take preventive treatments (like early HRT or vitamins) often have healthier baseline behaviors that skew observational data.